Paper58199
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
Sagar S and 6 others. Lancet, 1976. Cited by 197 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Papers, record 58199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58199
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparin | Major topic |
| Hip Joint | Major topic |
| Joint Prosthesis | Major topic |
| Thrombophlebitis | Major topic |
| Clinical Trials as Topic | |
| Dihydroergotamine | |
| Drug Evaluation | |
| Female | |
| Femoral Vein | |
| Follow-Up Studies | |
| Hematoma | |
| Humans | |
| Male | |
| Middle Aged | |
| Postoperative Complications | |
| Prospective Studies | |
| Pulmonary Embolism |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27,517,405 | Dextran prophylaxis in total hip replacement: A scintigraphic evaluation of the incidence of deep vein thrombosis and pulmonary embolus. | Ir J Med Sci | 1979 | https://conductscience.org/library/papers/27517405 | PubMed |
| 22,084,658 | New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty. | Thrombosis | 2010 | https://conductscience.org/library/papers/22084658 | PubMed |
| 8,929,385 | Prevalence of deep venous thrombosis in the lower extremities of children in the intensive care unit. | Pediatr Radiol | 1996 | https://conductscience.org/library/papers/8929385 | PubMed |
| 7,257,029 | The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy. | Urol Res | 1981 | https://conductscience.org/library/papers/7257029 | PubMed |
| 7,233,920 | Prevention of postoperative deep vein thrombosis in Sweden: results of a survey. | World J Surg | 1980 | https://conductscience.org/library/papers/7233920 | PubMed |
| 6,876,691 | Antithrombin III deficiency in ischaemic stroke. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6876691 | PubMed |
| 6,767,449 | Prophylaxis of venous thromboembolism: analysis of cost effectiveness. | Ann Surg | 1980 | https://conductscience.org/library/papers/6767449 | PubMed |
| 6,355,715 | [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?]. | Langenbecks Arch Chir | 1983 | https://conductscience.org/library/papers/6355715 | PubMed |
| 6,192,998 | The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6192998 | PubMed |
| 6,188,763 | Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur. | J Clin Pathol | 1983 | https://conductscience.org/library/papers/6188763 | PubMed |
| 6,164,655 | Thromboembolism after hip surgery. | Int Orthop | 1981 | https://conductscience.org/library/papers/6164655 | PubMed |
| 1,655,136 | Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. | BMJ | 1991 | https://conductscience.org/library/papers/1655136 | PubMed |
| 1,336,131 | Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. | Neurosurg Rev | 1992 | https://conductscience.org/library/papers/1336131 | PubMed |
| 1,314,065 | Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group. | Arch Orthop Trauma Surg | 1992 | https://conductscience.org/library/papers/1314065 | PubMed |
| 990,839 | Prevention of postoperative deep venous thrombosis. | Br Med J | 1976 | https://conductscience.org/library/papers/990839 | PubMed |
| 884,445 | Femoral vein thrombosis and total hip replacement. | Br Med J | 1977 | https://conductscience.org/library/papers/884445 | PubMed |
| 697,431 | Failure of low dose heparin to prevent pulmonary embolism after hip surgery or above the knee amputation. | Ann Surg | 1978 | https://conductscience.org/library/papers/697431 | PubMed |
| 656,796 | [Deep-vein thrombosis after hip replacement]. | Br Med J | 1978 | https://conductscience.org/library/papers/656796 | PubMed |
| 466,100 | Can we really prevent postoperative pulmonary emboli? | Br Med J | 1979 | https://conductscience.org/library/papers/466100 | PubMed |
| 351,980 | The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. | World J Surg | 1978 | https://conductscience.org/library/papers/351980 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/58199
GET https://conductscience.org/api/papers/v1/58199/cited_by?page=2